Topiramate Capsule, Extended Release
Product Images NDC 68462-372

11 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68462-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient topiramate, as represented in a molecular diagram showing its specific atomic and chemical bonding arrangement.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A cumulative rate plot showing time to first seizure for patients taking topiramate at doses of 50 mg/day and 400 mg/day over approximately 500 days. The graph compares seizure occurrence between the two dosage groups with cumulative rates on the vertical axis and time in days on the horizontal axis.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A bar chart comparing the proportion of patients (%) experiencing different levels of seizure frequency reduction from baseline, categorized by placebo and topiramate 200 mg/day treatment groups. The x-axis represents the percentage reduction in seizure frequency, and the y-axis shows the proportion of patients.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A bar graph depicting the change from baseline to double-blind phase in average monthly migraine period rate for topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day compared to placebo. The chart shows results from two studies with error bars and significance indicators (* and **) for p-values, illustrating dose-related decreases in migraine period rates.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

25mg30slbl (25mg30slbl)

25mg30slbl (25mg30slbl)
Topiramate Extended-Release Capsules 25 mg package label from Glenmark Pharmaceuticals Inc., USA. The label indicates 30 capsules for oral use with once-daily dosing. It includes dosing instructions and storage information, along with pharmacy dispensing guidance and a barcode.*
FDA Label Image

50mg30slbl (50mg30slbl)

50mg30slbl (50mg30slbl)
Label for Topiramate Extended-Release Capsules 50 mg by Glenmark Pharmaceuticals Inc., USA. The label indicates once-daily dosing and contains 30 capsules. Storage instructions advise keeping the capsules in a tight container at controlled room temperature and protecting from moisture. The label also includes a Medication Guide URL and distributor contact information.*
FDA Label Image

100mg30slbl (100mg30slbl)

100mg30slbl (100mg30slbl)
Topiramate Extended-Release Capsules 100 mg oral dosage form by Glenmark Pharmaceuticals Inc., USA. The label indicates once-daily dosing with 30 capsules per bottle. It includes storage instructions, safety precautions, and pharmacist dispensing advice. The National Drug Code (NDC) is 68462-374-30.*
FDA Label Image

150mg30slbl (150mg30slbl)

150mg30slbl (150mg30slbl)
Label for Topiramate Extended-Release Capsules 150 mg by Glenmark Pharmaceuticals Inc., USA. The label shows the dosage strength of 150 mg, packaging of 30 capsules, and includes instructions for pharmacists, recommended dosing as once daily, storage conditions, and distributor information. The label also features NDC code 68462-370-30 and contact details for questions.*
FDA Label Image

200mg30slbl (200mg30slbl)

200mg30slbl (200mg30slbl)
Topiramate Extended-Release Capsules 200 mg label by Glenmark Pharmaceuticals Inc., USA. The label indicates once-daily dosing, contains 30 capsules, and includes pharmacist instructions to dispense the Medication Guide. Storage instructions and contact details for Glenmark Pharmaceuticals are also present alongside an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.